search
Back to results

Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy

Primary Purpose

Spinal Muscular Dystrophy, Neuromuscular Disability

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Assisted Standing Treatment Program
Sponsored by
Gillette Children's Specialty Healthcare
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Muscular Dystrophy focused on measuring SMA, Neuromuscular disability

Eligibility Criteria

3 Years - 14 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age 3-14 years old
  2. Diagnosed with Spinal Muscular Atrophy (SMA)
  3. Participating in a standing program using a stationary assisted standing device.
  4. Gross Motor Function Classification System (GMFCS) Level IV or V
  5. Parent must be able to provide consent.

Exclusion Criteria:

1. Currently on bisphosphonates

Sites / Locations

  • Gillette Children's Specialty Healthcare

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Load-measuring platform

Arm Description

Load-sensing platform A load-sensing platform will be placed under each foot of the subject to record the time course of load borne by each of the lower extremities during weight-bearing training in an assisted standing device. Intervention: Assisted Standing Treatment Program. Assisted standing treatment program will gradually increase their duration of standing by up to 75% after the baseline phase.

Outcomes

Primary Outcome Measures

Collection of load magnitude and duration data (Use load-sensing platforms to collect load magnitude and duration during standing treatment program)
Use load-sensing platforms to collect load magnitude and duration during standing treatment program.

Secondary Outcome Measures

Bone Mineral Density
Determine whether an increase in the duration of standing leads to improvements in BMD, fracture incidence, pulmonary function and quality of life, and whether there is evidence that relationships exist between these outcome measures and load magnitude and duration.

Full Information

First Posted
January 2, 2015
Last Updated
February 16, 2021
Sponsor
Gillette Children's Specialty Healthcare
Collaborators
University of Minnesota
search

1. Study Identification

Unique Protocol Identification Number
NCT02341053
Brief Title
Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy
Official Title
Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy
Study Type
Interventional

2. Study Status

Record Verification Date
February 2021
Overall Recruitment Status
Completed
Study Start Date
September 8, 2016 (Actual)
Primary Completion Date
July 25, 2018 (Actual)
Study Completion Date
July 25, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Gillette Children's Specialty Healthcare
Collaborators
University of Minnesota

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Non-ambulatory children with a neuromuscular disability such as spinal muscular atrophy (SMA) are at significant risk for poor bone health as defined by low bone mineral density (BMD) and increased propensity to fracture. Poor bone health is thought to be related, at least in part, to abnormally low levels of load experienced by the skeleton. A common physical approach for increasing bone density is to stimulate the musculoskeletal system by increasing the amount and duration of weight-bearing in the lower extremities. For non-ambulatory individuals, this takes the form of using an assisted standing device to enable the child to spend time in a standing position with some degree of weight placed on the lower limbs. Some of these physical interventions demonstrate variable improvement in BMD in children with neuromuscular conditions, and some do not. A serious limitation in the previous work in this area is a failure to objectively measure the magnitude and duration of the loading experienced by the lower extremities. Thus, a lack of change in BMD may be due to the extremities experiencing only a fraction of the body weight (due to load-sharing with the assistive device) for an inadequate duration of standing time. In order to investigate the efficacy of standing treatment for increasing BMD, the investigators will develop a simple, portable and inexpensive transducer that will measure the magnitude and time course of the load experienced by the lower extremities of individuals with SMA who use a stationary assisted standing device. The specific goal of this proposed project will be to develop, validate and establish the initial feasibility of such a measurement device.
Detailed Description
Background: Non-ambulatory children with a neuromuscular disability such as spinal muscular atrophy (SMA) are at significant risk for poor bone health as defined by low bone mineral density (BMD) and increased propensity to fracture. Poor bone health is thought to be related, at least in part, to abnormally low levels of load experienced by the skeleton. A common physical approach for increasing bone density is to stimulate the musculoskeletal system by increasing the amount and duration of weight-bearing in the lower extremities. For non-ambulatory individuals, this takes the form of using an assisted standing device to enable the child to spend time in a standing position with some degree of weight placed on the lower limbs. Some of these physical interventions demonstrate variable improvement in BMD in children with neuromuscular conditions, and some do not. A serious limitation in the previous work in this area is a failure to objectively measure the magnitude and duration of the loading experienced by the lower extremities. Thus, a lack of change in BMD may be due to the extremities experiencing only a fraction of the body weight (due to load-sharing with the assistive device) for an inadequate duration of standing time. Methods: In order to investigate the efficacy of standing treatment for increasing BMD, we will develop a simple, portable and inexpensive transducer that will measure the magnitude and time course of the load experienced by the lower extremities of individuals with SMA who use a stationary assisted standing device. This transducer will consist of an array of sensors embedded within a mat that will be placed under an individual's feet while they are in assisted standing. A prototype will be validated by comparing the output of this load-sensing mat against known loads that will be applied to the surface of the mat statically. The specific characteristics of the loading in the lower extremities of subjects can then be correlated with changes in their BMD to obtain a true outcome assessment. As a demonstration of this approach, we will recruit 3 children with SMA from Gillette Children's Specialty Healthcare who are currently participating in a standing program. Once enrolled and informed consent is obtained, the participants will use the mat provided to them to collect load and duration data during a baseline period where they will continue their standing program, and during a subsequent intervention period where they will increase the duration of their standing. The specific goal of this proposed project will be to develop, validate and establish the initial feasibility of such a measurement device. Implications: Successful completion of this proposed project will provide the necessary groundwork to move forward with a multicenter clinical trial on a large number of subjects with a variety of neuromuscular conditions. The measurement device will allow us to correlate change in BMD with the specific load history for each participant, thereby allowing us to determine whether physical interventions can lead to increased BMD in individuals with neuromuscular disabilities. Analysis of the data will help define a dose-dependent relationship between load, duration and changes in BMD, thereby guiding providers and therapists in prescribing standing interventions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Muscular Dystrophy, Neuromuscular Disability
Keywords
SMA, Neuromuscular disability

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
4 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Load-measuring platform
Arm Type
Other
Arm Description
Load-sensing platform A load-sensing platform will be placed under each foot of the subject to record the time course of load borne by each of the lower extremities during weight-bearing training in an assisted standing device. Intervention: Assisted Standing Treatment Program. Assisted standing treatment program will gradually increase their duration of standing by up to 75% after the baseline phase.
Intervention Type
Other
Intervention Name(s)
Assisted Standing Treatment Program
Intervention Description
Assisted Standing Treatment Program - Assisted standing treatment program will be gradually increase duration of standing by up to 75% after baseline.
Primary Outcome Measure Information:
Title
Collection of load magnitude and duration data (Use load-sensing platforms to collect load magnitude and duration during standing treatment program)
Description
Use load-sensing platforms to collect load magnitude and duration during standing treatment program.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Bone Mineral Density
Description
Determine whether an increase in the duration of standing leads to improvements in BMD, fracture incidence, pulmonary function and quality of life, and whether there is evidence that relationships exist between these outcome measures and load magnitude and duration.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 3-14 years old Diagnosed with Spinal Muscular Atrophy (SMA) Participating in a standing program using a stationary assisted standing device. Gross Motor Function Classification System (GMFCS) Level IV or V Parent must be able to provide consent. Exclusion Criteria: 1. Currently on bisphosphonates
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Walter Truong, MD
Organizational Affiliation
Gillette Children's Specialty Healthcare
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gillette Children's Specialty Healthcare
City
Saint Paul
State/Province
Minnesota
ZIP/Postal Code
55101
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy

We'll reach out to this number within 24 hrs